Ryan S. Funk

1.1k total citations
43 papers, 782 citations indexed

About

Ryan S. Funk is a scholar working on Hematology, Rheumatology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ryan S. Funk has authored 43 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 11 papers in Rheumatology and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ryan S. Funk's work include Autoimmune and Inflammatory Disorders Research (14 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Acute Lymphoblastic Leukemia research (7 papers). Ryan S. Funk is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (14 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Acute Lymphoblastic Leukemia research (7 papers). Ryan S. Funk collaborates with scholars based in United States, Saudi Arabia and Italy. Ryan S. Funk's co-authors include Jeffrey P. Krise, Mara L. Becker, Chad Pope, David B. Buckley, Faraz Kazmi, Andrew Parkinson, Roger A. Rajewski, Leon van Haandel, Jacob T. Brown and Susan M. Abdel‐Rahman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Biochemistry.

In The Last Decade

Ryan S. Funk

42 papers receiving 765 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan S. Funk United States 14 286 113 107 90 86 43 782
Hiromitsu Yokota Japan 20 579 2.0× 114 1.0× 47 0.4× 90 1.0× 109 1.3× 60 1.1k
Thomas C. Knauss United States 19 400 1.4× 168 1.5× 121 1.1× 102 1.1× 88 1.0× 33 1.4k
Elizabeth Kuo United States 12 366 1.3× 63 0.6× 39 0.4× 54 0.6× 64 0.7× 15 872
Ralf Miesel Germany 20 257 0.9× 143 1.3× 34 0.3× 40 0.4× 38 0.4× 39 931
An Chen China 21 577 2.0× 152 1.3× 42 0.4× 27 0.3× 235 2.7× 74 1.5k
C. L. Szumlanski United States 9 321 1.1× 146 1.3× 196 1.8× 48 0.5× 88 1.0× 13 864
Anna R. Wolfson United States 13 352 1.2× 65 0.6× 45 0.4× 53 0.6× 183 2.1× 29 1.5k
Ioannis Papageorgiou Greece 16 212 0.7× 76 0.7× 123 1.1× 58 0.6× 51 0.6× 35 727
Shujue Li China 18 386 1.3× 102 0.9× 109 1.0× 16 0.2× 137 1.6× 44 935
Yasushi Yamada Japan 17 494 1.7× 104 0.9× 73 0.7× 27 0.3× 80 0.9× 75 1.1k

Countries citing papers authored by Ryan S. Funk

Since Specialization
Citations

This map shows the geographic impact of Ryan S. Funk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan S. Funk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan S. Funk more than expected).

Fields of papers citing papers by Ryan S. Funk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan S. Funk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan S. Funk. The network helps show where Ryan S. Funk may publish in the future.

Co-authorship network of co-authors of Ryan S. Funk

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan S. Funk. A scholar is included among the top collaborators of Ryan S. Funk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan S. Funk. Ryan S. Funk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shakhnovich, Valentina, Marc Sudman, Daniel J. Lovell, et al.. (2024). Identification of Plasma Metabolomic Biomarkers of Juvenile Idiopathic Arthritis. Metabolites. 14(9). 499–499. 1 indexed citations
3.
4.
Bantis, Leonidas E., Rebekah L. Gundry, Ted R. Mikuls, et al.. (2022). Plasma metabolomic profiling as a tool to identify predictive biomarkers of methotrexate efficacy in rheumatoid arthritis. Seminars in Arthritis and Rheumatism. 56. 152056–152056. 7 indexed citations
5.
6.
Funk, Ryan S., et al.. (2021). Potential Role of Methotrexate Polyglutamates in Therapeutic Drug Monitoring for Pediatric Inflammatory Bowel Disease. Pharmaceuticals. 14(5). 463–463. 6 indexed citations
7.
Oni‐Orisan, Akinyemi, Thu T. Nguyen, Geoffrey H. Tison, et al.. (2021). Leveraging innovative technology to generate drug response phenotypes for the advancement of biomarker‐driven precision dosing. Clinical and Translational Science. 14(3). 784–790. 2 indexed citations
8.
Springer, Jason & Ryan S. Funk. (2021). Dose-dependent Pharmacological Response to Rituximab in the Treatment of Antineutrophil Cytoplasmic Antibody-associated Vasculitis. The Journal of Rheumatology. 48(11). 1718–1724. 3 indexed citations
9.
Funk, Ryan S. & Mara L. Becker. (2021). Metabolomic Profiling Identifies Exogenous and Microbiota-Derived Metabolites as Markers of Methotrexate Efficacy in Juvenile Idiopathic Arthritis. Frontiers in Pharmacology. 12. 768599–768599. 6 indexed citations
10.
11.
Gress, Kyle, et al.. (2020). Facing Real-World Challenges of Immunogenicity in Pediatric Inflammatory Bowel Disease. Frontiers in Immunology. 11. 1148–1148. 2 indexed citations
12.
Hicks, J. Kevin, Christina L. Aquilante, Henry M. Dunnenberger, et al.. (2019). Precision pharmacotherapy: Integrating pharmacogenomics into clinical pharmacy practice. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2(3). 303–313. 54 indexed citations
13.
Singh, Rakesh K., Leon van Haandel, Daniel P. Heruth, et al.. (2018). Nicotinamide Phosphoribosyltransferase Deficiency Potentiates the Antiproliferative Activity of Methotrexate through Enhanced Depletion of Intracellular ATP. Journal of Pharmacology and Experimental Therapeutics. 365(1). 96–106. 6 indexed citations
14.
15.
Kazmi, Faraz, et al.. (2013). Lysosomal Sequestration (Trapping) of Lipophilic Amine (Cationic Amphiphilic) Drugs in Immortalized Human Hepatocytes (Fa2N-4 Cells). Drug Metabolism and Disposition. 41(4). 897–905. 188 indexed citations
16.
Funk, Ryan S., Leon van Haandel, Mara L. Becker, & J. Steven Leeder. (2013). Low-Dose Methotrexate Results in the Selective Accumulation of Aminoimidazole Carboxamide Ribotide in an Erythroblastoid Cell Line. Journal of Pharmacology and Experimental Therapeutics. 347(1). 154–163. 17 indexed citations
17.
Funk, Ryan S., et al.. (2012). Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications. Expert Opinion on Drug Metabolism & Toxicology. 8(8). 943–958. 26 indexed citations
18.
Funk, Ryan S., Jacob T. Brown, & Susan M. Abdel‐Rahman. (2012). Pediatric Pharmacokinetics. Pediatric Clinics of North America. 59(5). 1001–1016. 41 indexed citations
19.
Stewart, Allison J., et al.. (2010). Cortisol and ACTH concentrations in ill horses throughout 6 days of hospitalization. Journal of Veterinary Emergency and Critical Care. 3 indexed citations
20.
Lane, Thomas A., Douglas H. Smith, Edward V. Wancewicz, & Ryan S. Funk. (1992). Inhibition of Endotoxin-Mediated Activation of Endothelial Cells by a Perfluorocarbon Emulsion. Biomaterials Artificial Cells and Immobilization Biotechnology. 20(2-4). 1051–1057. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiromitsu Yokota Breakdown of academic impact, for papers by Thomas C. Knauss Breakdown of academic impact, for papers by Elizabeth Kuo Breakdown of academic impact, for papers by Ralf Miesel Breakdown of academic impact, for papers by An Chen Breakdown of academic impact, for papers by C. L. Szumlanski Breakdown of academic impact, for papers by Anna R. Wolfson Breakdown of academic impact, for papers by Ioannis Papageorgiou Breakdown of academic impact, for papers by Shujue Li Breakdown of academic impact, for papers by Yasushi Yamada
Rankless by CCL
2026